11-74613007-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_006591.3(POLD3):c.389G>A(p.Ser130Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,607,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006591.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLD3 | NM_006591.3 | c.389G>A | p.Ser130Asn | missense_variant | 5/12 | ENST00000263681.7 | NP_006582.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLD3 | ENST00000263681.7 | c.389G>A | p.Ser130Asn | missense_variant | 5/12 | 1 | NM_006591.3 | ENSP00000263681.2 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000165 AC: 4AN: 243132Hom.: 0 AF XY: 0.0000304 AC XY: 4AN XY: 131446
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1455468Hom.: 0 Cov.: 30 AF XY: 0.00000553 AC XY: 4AN XY: 723894
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2024 | The c.389G>A (p.S130N) alteration is located in exon 5 (coding exon 5) of the POLD3 gene. This alteration results from a G to A substitution at nucleotide position 389, causing the serine (S) at amino acid position 130 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at